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Use of Tumor Diameter to Estimate the
Growth Kinetics of Cancer and Sensitivity
of Screening Tests
by Naohito Yamaguchi,* Takashi Yanagawa,t Takesumi
Yoshimura,* Norio Kohrogi,§ Keiji Tanaka," Yuichi
Nakamura,"1 and Toshiteru Okubo*
A statistical method has been developed that is useful for studying the relationship between the growth
kinetics of malignant tumors and the detection probability either through symptoms or by screening.
Mathematical modelsthatdescribe thedistribution ofpathologicalvariables inmalignanttumors, detected
after various histories ofscreening, are derived and parameters for detection probabilities and the growth
kinetics are then estimated by the maximum likelihood procedure. By this method the probabilities of
detection through symptoms as well as by screening can be estimated as functions of pathological vari-
able(s) such as tumor size. The growth rate of tumor can also be estimated from the distribution of
pathological variables. The present method was applied to gastric cancer in Japan, where an annual
screening program for the disease exists. The detection probability for the indirect X-ray used as the
screening test was estimated to be 0.323 x (diameter)2/[1 + 0.323 x (diameter)2]. The doubling time of
gastric cancer was estimated to be 2.90 months.
Introduction
The natural history of cancer consists oftwo different
stages: the stage of transformation and the stage of
growth. In the former stage, a normal cell is trans-
formed into a cancer cell by a series ofinheritable geno-
mic alterations; in the stage of growth, the cancer cell
multiplies and grows to a mass until it becomes large
enough to be clinically diagnosed due to symptoms. In
this paper we focus on this latter stage and discuss a
new method that is useful in describing the nature of
growth in this stage.
A malignant tumorin the stage ofgrowth is primarily
characterized by the state of its pathological or mor-
phological variables such as size of tumor, invasion of
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submucosa, and metastasis to lymph nodes or distant
organs. Thesepathologicalvariablesdeterminewhether
the tumor manifests any clinical symptoms and, there-
fore, whether it can be detected through symptoms.
These variables also determine the probability oftumor
detection by a screening test and the prognosis of the
individual after the tumor is detected.
The growth kinetics ofa malignant tumor, which can
be expressed as change in pathological variables with
time, is one of the major questions to be answered to
better understand the total picture of the process of
carcinogenesis. It also provides important information
useful for evaluating the potential impact of cancer
screening programs in terms ofthe degree ofimprove-
ment in prognosis.
In this paper a mathematical method is presented by
which the functional relationships between the patho-
logical variables of a tumor and the probability of de-
tection ofthe tumor, either through symptoms or by a
screening test, can be estimated from data of the dis-
tribution of pathological variables among cancers with
various histories of screening. The growth rate, ex-
pressed as the change in the pathological variables per
unit of time, can also be estimated by this method.
Though the pathological variables are numerous, we
choose here the maximum diameter (diameter, here-
after) oftumor as the quantitative measure ofthe path-
ological feature. The relationship between the distri-YAMAGUCHI ETAL.
butionofdiameterandthemodeofdetection(symptoms
versus screening) as well as the history of screening
before tumor detection is analyzed based on mathe-
matical models ofgrowth kinetics.
Assumptions
Detection of a Tumor through Symptoms
We assume that the only reason apatient with a ma-
lignant tumor seeks medical aid is because ofthe symp-
tom(s) manifested due to the tumor. We also assume
that the magnitude of the symptoms is related to the
pathological state ofthe tumor.
We use the following conditional probability:
,r(x) lim Pr{x
- LD < X+ dxILD ¢X}(1)
dlx--+O 0 dx
where x is the diameter ofthe tumor at a certain point
in time and LD is the diameter at detection through
symptoms.
Growth of Tumor
We assume that a tumor grows at arate proportional
to the number ofcancer cells in the tumor. This implies
that the growth oftumor is exponential.
x = a * exp(1 t), (2)
where t is the time measured from the start ofgrowth,
a is the diameter of a single cancer cell, and , is a
parameter related to the growth rate. We assume that
all tumors have the same value for ,.
Incidence
We assume that the incidence rate of the cancer in
the population involved is constant overtime. Since the
incidence rate may differ with age and other variables,
this assumption implies that the distribution of these
variables in the population does not change with time.
Detection by Screening Test
We assume that a person's decision to participate in
the annual screening program is not affected by the
existence of a tumor. We also assume that the ability
ofthe screening test concerned in detecting a tumor is
related to the pathological state of the tumor. We use
afunctionv(x)fortheprobability ofdetection ofatumor
with diameter x by the screening test.
Mathematical Formulation
In this section, the probability density functions of
diameter of tumors in various situations are derived
based on the assumptions previously mentioned. Situ-
ations discussed here are: when tumors are detected
through symptoms in a population with no history of
screening and when tumors are detected by (k + 1)'th
screen in persons who have k negative results in con-
secutive screens in the past (k = 0,1,2.... ).
Letf(xlk) denote the probability density function of
diameter x in tumors detected through symptoms in
personswhohavebeenexposedtokconsecutivescreens
andf8(xlk) the probability density function ofdiameter
x in tumors detected by (k + 1)'th screen in persons
who have been exposed to k consecutive screens.
Detection through Symptoms in a
Population without Screening
Suppose that we collect cancer cases of people who
were diagnosed in a population during a given period
[a, b]. If this penod is long enough to ensure that the
probability of a cancer's being included in the study is
independent of the age of tumor measured from the
start ofgrowth,
f,(xl0) = r(x) * exp - r(u)du]. (3)
Thus, r(x) can be estimated by analyzing the distribu-
tion ofdiameter in tumors detected through symptoms
in persons who have never been exposed to a screen.
Detection by Screening
Letus considerthe distributionofdiameterintumors
detected by (k + 1)'th screen in aperiodically screened
population. The probability that a tumor is detected
when the diameter falls into a short range (x, x + dx)
by a screen after k negative results in consecutive
screens with interval d in the past can be expressed as
the product of a) the probability that the tumor is not
detected through symptoms until the diameter reaches
x, b) the probability that the tumor is not detected by
the k screens inthe past, and c) the probabilitythat the
tumor of diameter x is detected by the last screening
test. Let P(x,k) denote this probability,
P(x,k) = exp[ - fr(u)du]
k
H n [1 - v( x))],
i=l
(4)
where xi denotes the diameter of the tumor at
(k-i+1)'th screen. xi = x * exp(- * d * i).
Based on the Bayes Theorem,
f8(xlk) = Pr{x
- L < x + dxlLD > X,
not detected by k screens,
detected by (k + 1)'th screen}
P(x,k) * h(x)
1L7 P(x,k) * h(x)dx
where L is the diameter of tumor, L1 and L4 are the
minimum and maximum values ofL and h(x) = Pr(x
-
L < x + dx). If h(x) is uniformly distributed,
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f(xlk) 2P(x,k) (5)
P(x,k)dx
Ifk = 0, i.e., in the patients with no history of screen-
ing,
P(x,0)
= exp r(u)du] v(x).
Thus, P(x,0) isindependentofthegrowthrate oftumor,
if h(x) is uniformly distributed.
f8(xIO) =
exp[ - u)dJ * v(x)
exp [ - r(u)du] v(x)dx
Application
In this section, the above method is applied to gastric
cancer inJapan.
Materials and Methods
Table 1 showsthedataofthedistributions ofdiameter
in gastric cancers ofvarious histories ofscreening. The
cases ofgastric cancers detected through symptoms are
from the Center for Adult Disease of Fukuoka City
Medical Association (CAD-FCMA). They were diag-
nosed as having gastric cancer during the period 1978
to 1981. Thecases ofgastric cancers detectedbyscreen-
ing are from CAD-FCMA and the Health Center of
Karatsu City. They were diagnosed as having gastric
Table 1. Distribution of diameter of gastric cancers which were
detected either through symptoms or by screening among people
with various histories of past screening.
Diameter, Detection group
cm la 2b 3c 4d
- 1 9 5 4 4
1- 2 18 20 7 10
2- 3 11 39 12 9
3- 4 11 33 12 6
4- 5 17 37 5 4
5- 6 16 26 4 2
6- 7 13 13 4 2
7- 8 9 9 1 0
8- 9 5 7 0 0
9- 10 4 4 1 1
10- 10 12 0 3
Total 123 205 50 41
aDetected through symptoms amongpeople with no history ofpast
screening.
bDetected by screening among people with no history of past
screening.
'Detected by screening among people with history ofone negative
result in the screening of 1 year before.
dDetected by screeningamongpeople with history oftwo negative
results in the past screenings of 1 and 2 years before.
cancer in these institutes after indirect X-ray exami-
nations as the screening test during the period 1969 to
1981.
Sincef,(xIO) is related only to r(x) as shown in Eq.
(3), r(x) is directly estimable from the observed distri-
bution (column 1 in Table 1). Forr(x), we chose polyno-
mials ofvarying degrees as follows:
I
r(x) = + x 'ir, (I = 1,2, .. .. (7)
Sincef,(xlO) is related only to r(x) as shown in Eq.
(6), v(x) isestimable fromthe observed distribution (col-
umn 2 in Table 1) by substituting i(x) in Eq. (6). For
v(x), we arbitrarily chose the following function:
g(x)
m
v(x) = g(x) = g (pi * xi, (m = 1,2,...).
The growth parameter i is estimable from the ob-
served distribution of diameter of tumors detected by
screening among people who have k negative results in
consecutive screenings in the past [Eq. (5)] by substi-
tuting ix() and vb(x) for r(x) and v(x). We chose gastric
cancers detected by screening after one negative result
in a screen 1 yearbefore (column 3 in Table 1) and those
detected by screening after two negative results in
screens 1 and 2 years before (column 4 in Table 1). A
loglikelihood function is formulated by combiningthese
two types of data.
The maximum likelihood estimates (MLEs) ofparam-
eters are calculated by the Newton-Raphson method,
and the best fit models are chosen from among various
models based on the Akaike Information Criterion
(AIC) (1).
Centimeters and months are used as the units for
diameter and time, respectively.
Results
Estimation of r(x). The AICs for polynomials of
degree 1 and 2 were 599.56 and 602.32, respectively.
Therefore, we chose the polynomial of degree one as
the best fit model for r(x). The MLEs and estimated
covariance matrix of parameters in the polynomial are
shown in Table 2.
The 95% confidence intervals of -9 and Pi are (0.0173,
0.1113) and (0.0230, 0.0546), respectively. Figure 1 il-
lustrates the observed distribution function and the dis-
tribution function calculated by A(x).
Estimation ofv(x). To calculate the MLEs of the
parameters in v(x), we first estimated the true distri-
Table 2. MLEs and estimated covariance matrix of parameters.
Covariance matrix
MLEs
n 0.0643 5.77 x 10-4 -1.45 x 10-4
sP1 0.0388 -1.45 x 10-4 6.48 x 10-4
i(x) = Ti + 4ix
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FIGURE 1. Observed (A-A) and fitted (-) distribution function of
diameter of gastric cancers detected through symptoms. LD de-
notes the diameter at detection through symptoms.
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FIGURE 2. Observed (0-0) and fitted (A-A) distribution of di-
ameter of gastric cancers detected by the first screening.
Table 3. AICs for various models of v(x).
Models [g(x)] AIC
81X 908.28
82X2 899.96
83X3 902.29
81X + 82X2 901.94
81X + 82x2 + 83X3 901.58
bution ofdiameter ofpreclinical tumors that are not yet
detected at a certain point in time by using Eq. (6) and
thenestimatingv(x) based onthe factthatthe difference
between the true and the observed relative frequencies
can be explained by the function v(x). The AICs for
various models of v(x) were as shown in Table 3.
So we chose the function of power 2 (model 2) as the
best fit function. The MLE and SE of62 were 0.323 and
0.110, respectively. Figure 2 illustrates the observed
distribution function of diameter in gastric cancers de-
tected by first screenings and the distribution function
1 2 3 4 5 6 7 9 8 10 11 12 13 14 16
Diameter (cm)
FIGURE 3. Probability ofdetection ofgastric cancer by the indirect
X-ray examination as a screening test.
calculated based on the estimated r(x) and v(x). Figure
3 illustrates the estimated v(x).
Estimation of Growth Parameter. Finally, the
MLE for a was obtained by substituting i(x) and v(x)
for r(x) and v(x) in Eq. [5] and by maximizing the com-
bined log likelihood of the data of diameter of gastric
cancers detected by screening with one and two nega-
tive results in the past. The MLE and SE are 0.239 and
0.158, respectively. Based on the MLE, the doubling
time of diameter in gastric cancer was estimated to be
2.90 months. By assuming that the diameter ofa single
cancer cell is 0.01 mm, the length oftime from the start
ofgrowth to the point at which the diameter reaches 5
cm was estimated to be 3.0 years.
Discussion
Mathematical theories concerningthe natural history
of cancer and early detection by screening have been
proposed by many researchers; one ofthe earliest stud-
ies was published by Zelen and Feinleib (2) as early as
1969. One of the finest mathematical theories is given
in a series of papers by Albert et al. (3), Albert et al.
(4), and Louis et al. (5). They formulated the natural
history of chronic disease state in terms of the distri-
bution ofthe age ofa person at the time ofentering the
disease state, the sojourntime inthat disease state, and
the person's present age. The formulation was used by
many authors for various studies. However, in the case
of cancer, it is difficult to observe the point in time at
which a cancer enters the preclinical state and even
moredifficult todefinethe state ofpreclinical stateitself
in a fashion that is useful for biostatistic research.
In the present study, we took into account the fact
that the primary determinant ofthe distribution of so-
journtime wasthe pathologicalvariables ofthegrowing
tumor, and based on this fact, we developed a mathe-
matical model by which the change in the pathological
variables over time can be estimated. As noted above,
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the pathological feature ofa tumor determines not only
whether it manifests any clinical symptoms but also
whether it can be detected by a screening test and even
determines the prognosis or curability of the patient
with the tumor. Thus, pathological variables seemmore
useful in describing the natural history of cancer than
the time measure itself.
Also, the present method enables us to estimate the
probability of detection by screening test as a function
ofthe pathological variables, in contrast to the models
introduced so far by other researchers (6,7), in which
they assume that the probability has the same value
throughout the entire preclinical period. The ability of
a screening test to detect a cancer of a certain size
cannot be measured directly from screening data, since
falsenegative cases are notaccessible. Themethodused
to calculate the false negative rate is usually to review
thepastX-rayfilmsofindividuals inwhomcancerswere
later found. However, this method may give biased re-
sults, since the probability ofdetection by screening is
related not only to the ability ofthe test used but also
to the pathological features of the tumor, and this
method cannot take into account the latter factor.
In the present study, we assumed that all cancers of
a certain site have the same growth rate. This assump-
tion may be replaced by a weaker assumption that the
growth rate differs in individual cases following a cer-
tain distribution family such as log normal distribution.
Although the results are not presented in this paper,
according to the simulation we conducted to compare
the fixed growth rate model with the random growth
ratemodelwith P, lognormallydistributed showedgood
agreement for various values of P and its standard de-
viation.
The data to which we applied our method were not
obtained from a population to which a screening pro-
gram was randomly assigned. Ifthe method is applied
to data obtained through a randomized controlled trial,
the validity of results will be increased. However, it
should be noted that an analysis ofexisting data based
on the method presented in this study can provide im-
portant information on the natural history of cancer
fairly efficiently if the assumptions made on the data
and model are plausible from a biological viewpoint.
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